title: Tumor lysis syndrome following a single dose of capecitabine.
authors.forename: Mevlüt
authors.initials: M
authors.lastname: Kurt
authors.forename: Orhan Onder
authors.initials: OO
authors.lastname: Eren
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Engin
authors.forename: Nilüfer
authors.initials: N
authors.lastname: Güler
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000031:analogs & derivatives; D006801:Humans; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil